The expression of each and all three PDE3A variants sensitized DNMDP-treated cells, suggesting that the expression of PDE3A indeed regulates DNMDP sensitivity in cervical cancer cells (Figure 5B). This evidence concerns the gene PDE3A and cervical carcinoma.